Detalhe da pesquisa
1.
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.
J Neurol Neurosurg Psychiatry
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777579
2.
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients.
Cephalalgia
; 42(8): 804-809, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35166156
3.
Influence of the COVID-19 outbreak in people with epilepsy: Analysis of a Spanish population (EPICOVID registry).
Epilepsy Behav
; 112: 107396, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32911299
4.
Low-value care practice in headache: a Spanish mixed methods research study.
J Headache Pain
; 21(1): 74, 2020 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32522142
5.
Quality assurance in specialized headache units in Spain: an observational prospective study.
J Headache Pain
; 20(1): 73, 2019 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31238877
6.
Proposal of a clinical care pathway for quality and safe management of headache patients: a consensus study report.
BMJ Open
; 10(10): e037190, 2020 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33127628
7.
Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.
Neurology
; 95(8): e1060-e1070, 2020 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32482845
8.
Erenumab for the treatment of chronic resistant migraine. / Erenumab para el tratamiento de migraña crónica farmacorresistente.
Med Clin (Barc)
; 158(2): 96-97, 2022 01 21.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-34074481